AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12888042 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg/ml ICG
Number of subjects: 28
Study 12888042 — intervention group
Group type: COMPARATOR
Intervention: Control (0.25 mg/ml and 0.5 mg/ml ICG)
Number of subjects: 28
Study 10472355 — intervention group
Group type: EXPERIMENTAL
Intervention: Photon therapy (median dose 60 Gy, range 45 to 65 Gy)
Number of subjects: 161
Study 10472355 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron therapy (median dose 14.1 Gy, range 5.0 to 18.57 Gy)
Number of subjects: 161
Study 10472355 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-beam irradiation (average dose 36.5 Gy photon and 8.5 Gy neutrons)
Number of subjects: 161
Study 8923090 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon gamma 100 ug subcutaneously daily for up to 21 days
Number of subjects: 416
Study 8923090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study 1762007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ender nailing
Number of subjects: 220
Study 1762007 — intervention group
Group type: COMPARATOR
Intervention: Sliding screw plate (SSP)
Number of subjects: 220
Study 6760063 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution administered at 9 a.m.
Number of subjects: 8
Study 6760063 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution administered at 9 p.m.
Number of subjects: 8
Study 6760063 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution (both morning and evening)
Number of subjects: 8
Study 3882015 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective vagotomy with pyloroplasty
Number of subjects: 161
Study 3882015 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy with pyloroplasty
Number of subjects: 161
Study 3882015 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy
Number of subjects: 161
Study 3882015 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 161
Study 30017826 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of vilanterol (25 μg) + fluticasone furoate (100 μg)
Number of subjects: 14
Study 30017826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30017826 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone furoate (100 μg)
Number of subjects: 14
Study 26613661 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors with short education
Number of subjects: 369
Study 26613661 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors living alone
Number of subjects: 369
Study 26613661 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully adjusted model
Number of subjects: 369
Study 25062857 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour retest interval
Number of subjects: 34
Study 25062857 — intervention group
Group type: COMPARATOR
Intervention: >6-days retest interval
Number of subjects: 34
Study 22407175 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer variability in measurements of bidimensional products (BPs) of tumor diameter
Number of subjects: 10
Study 19958206 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO(2) mixture
Number of subjects: 15
Study 19958206 — intervention group
Group type: COMPARATOR
Intervention: Atmospheric compressed air
Number of subjects: 15
Study 18936577 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive coronary artery bypass grafting (miniCABG)
Number of subjects: 200
Study 18936577 — intervention group
Group type: COMPARATOR
Intervention: Traditional sternotomy CABG
Number of subjects: 200
Study 15897793 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 prepaid monetary incentive
Number of subjects: 3900
Study 15897793 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentive (chance to win one of ten $100 prize drawings)
Number of subjects: 3900
Study 15897793 — intervention group
Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 3900
Study 14703410 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene therapy + radiotherapy (GTRT group, n = 16)
Number of subjects: 29
Study 14703410 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT group, n = 213)
Number of subjects: 29
Study 10617311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue exposure (CE)
Number of subjects: 50
Study 10617311 — intervention group
Group type: COMPARATOR
Intervention: Control group (neutral beverage)
Number of subjects: 50
Study 8538479 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate (EV, 2 mg/day for 21 days) with cyproterone acetate (CPA, 1 mg/day in the last 10 days of the treatment cycle)
Number of subjects: 31
Study 8538479 — intervention group
Group type: COMPARATOR
Intervention: Oral calcium (500 mg/day)
Number of subjects: 31
Study 1659358 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran bread
Number of subjects: 12
Study 1659358 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran bread
Number of subjects: 12
Study 7333345 — intervention group
Group type: EXPERIMENTAL
Intervention: Theolair Retard 250 mg sustained release tablet
Number of subjects: 8
Study 31608677 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient balance training intervention (4 weeks)
Number of subjects: 86
Study 31608677 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary balance training intervention (4 weeks)
Number of subjects: 86
Study 31608677 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 86
Study 30218653 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-barrel fibular flap (DBFF)
Number of subjects: 26
Study 30218653 — intervention group
Group type: COMPARATOR
Intervention: Single-barrel fibular flap (SBFF)
Number of subjects: 26
Study 30419858 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy added to chemo-radiotherapy
Number of subjects: 85
Study 26922296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg
Number of subjects: 312
Study 26922296 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 312
Study 23135413 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented tibial fixation (n=48)
Number of subjects: 93
Study 23135413 — intervention group
Group type: COMPARATOR
Intervention: Cementless fixation with screw augmentation (n=45)
Number of subjects: 93
Study 25324618 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated rehabilitation program
Number of subjects: 90
Study 25324618 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine outpatient care)
Number of subjects: 90
Study 25324618 — intervention group
Group type: EXPERIMENTAL
Intervention: Guardians of patients in the intervention group
Number of subjects: 90
Study 25324618 — intervention group
Group type: COMPARATOR
Intervention: Guardians of patients in the control group
Number of subjects: 90
Study 20193089 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga practice for one hour daily for one week
Number of subjects: 22
Study 20193089 — intervention group
Group type: COMPARATOR
Intervention: Non-yoga wait-list control group
Number of subjects: 22
Study 18072052 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 L of polyethylene glycol (PEG) solution
Number of subjects: 90
Study 18072052 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L of polyethylene glycol (PEG) solution
Number of subjects: 90
Study 18072052 — intervention group
Group type: COMPARATOR
Intervention: Clear liquid diet and overnight fast (no PEG solution)
Number of subjects: 90
Study 16271342 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐mg nicotine enemas
Number of subjects: 104
Study 16271342 — intervention group
Group type: COMPARATOR
Intervention: Placebo enemas
Number of subjects: 104
Study 16271342 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐mg nicotine enemas in patients taking mesalamine
Number of subjects: 104
Study 16271342 — intervention group
Group type: COMPARATOR
Intervention: Placebo enemas in patients taking mesalamine
Number of subjects: 104
Study 11583888 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN, 0.6 mg/h/24 h for six days
Number of subjects: 16
Study 11583888 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 16
Study 11583888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 16
Study 9622211 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin (therapeutic subcutaneous doses)
Number of subjects: 0
Study 7888287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 20
Study 7888287 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/Z0K 100 mg
Number of subjects: 20
Study 7888287 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/Z0K 50 mg
Number of subjects: 20
Study 7888287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3352163 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (BCAA) infusion
Number of subjects: 5
Study 3352163 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids mixture
Number of subjects: 5
Study 3352163 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 5
Study 31857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic version of the Evaluating Respiratory Symptoms in COPD (E-RS)
Number of subjects: 81
Study 31857313 — intervention group
Group type: COMPARATOR
Intervention: Paper version of the Evaluating Respiratory Symptoms in COPD (E-RS)
Number of subjects: 81
Study 31857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic version of the COPD Assessment Test (CAT)
Number of subjects: 81
Study 31857313 — intervention group
Group type: COMPARATOR
Intervention: Paper version of the COPD Assessment Test (CAT)
Number of subjects: 81
Study 28835380 — intervention group
Group type: EXPERIMENTAL
Intervention: BL-8040 (1 mg/kg)
Number of subjects: 8
Study 28835380 — intervention group
Group type: COMPARATOR
Intervention: BL-8040 (0.5 mg/kg)
Number of subjects: 8
Study 28835380 — intervention group
Group type: EXPERIMENTAL
Intervention: BL-8040 (0.75 mg/kg)
Number of subjects: 8
Study 28835380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 26193372 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-down positioning (fdp)
Number of subjects: 30
Study 23669458 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs that accepted public insurance
Number of subjects: 13328
Study 23669458 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs with staff involvement and linkages with minority communities
Number of subjects: 13328
Study 23669458 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs with culturally responsive policies and assessment and treatment practices
Number of subjects: 13328
Study 21306916 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (acceleration: from 12 to 89 ms(‐2))
Number of subjects: 23
Study 21306916 — intervention group
Group type: COMPARATOR
Intervention: Conventional squat exercise on Smith machine (weight: from 20 to 70 kg)
Number of subjects: 23
Study 21306916 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration
Number of subjects: 23
Study 21306916 — intervention group
Group type: COMPARATOR
Intervention: Conventional squat exercise on Smith machine
Number of subjects: 23
Study 19301201 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 80
Study 19301201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 17226044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (21 days treatment)
Number of subjects: 0
Study 17226044 — intervention group
Group type: COMPARATOR
Intervention: Estradiol-only (E(2))
Number of subjects: 0
Study 17226044 — intervention group
Group type: COMPARATOR
Intervention: E(2) + Medroxyprogesterone Acetate (E(2) + MPA)
Number of subjects: 0
Study 15490767 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple therapy included in inpatient treatment (15 patients)
Number of subjects: 31
Study 15490767 — intervention group
Group type: COMPARATOR
Intervention: Standard inpatient treatment without partner therapy (16 patients)
Number of subjects: 31
Study 11902819 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormone replacement therapy (oestradiol 2 mg and norethisterone acetate 1 mg per day)
Number of subjects: 61
Study 11902819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 9357881 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 48
Study 9357881 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 48
Study 7680947 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneovenous shunts (PVS)
Number of subjects: 85
Study 7680947 — intervention group
Group type: COMPARATOR
Intervention: Abdominal paracentesis
Number of subjects: 85
Study 3081935 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol placebo
Number of subjects: 14
Study 3081935 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 14
Study 31574544 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen Rich Water (HRW)
Number of subjects: 12
Study 31574544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29247498 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 48
Study 29247498 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 48
Study 29247498 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 48
Study 27046802 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (24 classes, 45 minutes each, during 3 months)
Number of subjects: 176
Study 27046802 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong (12 classes, 90 minutes each, during 3 months)
Number of subjects: 176
Study 27046802 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 176
Study 24235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcalcetide 0.5 mg
Number of subjects: 64
Study 24235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcalcetide 2 mg
Number of subjects: 64
Study 24235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcalcetide 5 mg
Number of subjects: 64
Study 24235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcalcetide 10 mg
Number of subjects: 64
Study 24235081 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcalcetide
Number of subjects: 64
Study 24235081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 22777096 — intervention group
Group type: EXPERIMENTAL
Intervention: JE-CV from industrial scale lot (n = 899)
Number of subjects: 1200
Study 22777096 — intervention group
Group type: EXPERIMENTAL
Intervention: JE-CV from development lot (n = 199)
Number of subjects: 1200
Study 22777096 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis A control vaccine (n = 102)
Number of subjects: 1200
Study 19737735 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention (n=59)
Number of subjects: 504
Study 19737735 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=60)
Number of subjects: 504
Study 18176316 — intervention group
Group type: EXPERIMENTAL
Intervention: Septic shock context for cardiomyopathy case
Number of subjects: 0
Study 18176316 — intervention group
Group type: COMPARATOR
Intervention: Uneventful clinic visit context for cardiomyopathy case
Number of subjects: 0
Study 18176316 — intervention group
Group type: COMPARATOR
Intervention: Lung cancer case presented before cardiomyopathy
Number of subjects: 0
Study 18176316 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer case presented after cardiomyopathy
Number of subjects: 0
Study 18176316 — intervention group
Group type: EXPERIMENTAL
Intervention: Phrasing of inquiry for lung cancer
Number of subjects: 0
Study 16125368 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 1580
Study 16125368 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention against cannabis use
Number of subjects: 1580
Study 12891099 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency obliteration (RFO)
Number of subjects: 85
Study 12891099 — intervention group
Group type: COMPARATOR
Intervention: Stripping and high ligation (S&L)
Number of subjects: 85
Study 10561349 — intervention group
Group type: EXPERIMENTAL
Intervention: Dartmouth regimen (dacarbazine 220 mg/m², cisplatin 25 mg/m² days 1 to 3, carmustine 150 mg/m² day 1 every other cycle, tamoxifen 10 mg orally bid)
Number of subjects: 240
Study 10561349 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine 1,000 mg/m²
Number of subjects: 240
Study 10561349 — intervention group
Group type: EXPERIMENTAL
Intervention: Dartmouth regimen
Number of subjects: 240
Study 10561349 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 240
Study 8556879 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sensorimotor treatment (OST)
Number of subjects: 35
Study 8556879 — intervention group
Group type: COMPARATOR
Intervention: Chewing exercises alone
Number of subjects: 35
Study 8556879 — intervention group
Group type: COMPARATOR
Intervention: Oral sensorimotor treatment (OST) and Chewing exercises
Number of subjects: 35
Study 8369192 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous solution of iohexol (9 mg I/ml)
Number of subjects: 0
Study 8369192 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous preparation of iohexol (9 mg I/ml)
Number of subjects: 0
Study 8369192 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous solution of amidotrizoate (9 mg I/ml)
Number of subjects: 0
Study 8369192 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solutions of iohexol and amidotrizoate
Number of subjects: 0
Study 3530610 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine with Methacholine
Number of subjects: 8
Study 3530610 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine-Methacholine
Number of subjects: 8
Study 3530610 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine-Adenosine
Number of subjects: 8
Study 30287601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®-fC) for couples, duration 10 weeks
Number of subjects: 0
Study 30287601 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 0
Study 30287601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®-fC) for couples
Number of subjects: 0
Study 27182021 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure using vaccaria seeds
Number of subjects: 58
Study 24019207 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt with low calorie diet (PLCD)
Number of subjects: 75
Study 24019207 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt without low calorie diet (PWLCD)
Number of subjects: 75
Study 24019207 — intervention group
Group type: COMPARATOR
Intervention: Regular yogurt as part of a low calorie diet (RLCD)
Number of subjects: 75
Study 24019207 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 75
Study 21559322 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine treatment
Number of subjects: 0
Study 21559322 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacological intervention)
Number of subjects: 0
Study 19761935 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 104
Study 19761935 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 104
Study 17693328 — intervention group
Group type: EXPERIMENTAL
Intervention: OCPs pretreatment (Group A)
Number of subjects: 19
Study 17693328 — intervention group
Group type: COMPARATOR
Intervention: No OCPs pretreatment (Group B)
Number of subjects: 19
Study 15339408 — intervention group
Group type: EXPERIMENTAL
Intervention: Baisuifang Granule
Number of subjects: 160
Study 15339408 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 160
Study 11464232 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (oral antioxidant dietary supplement)
Number of subjects: 40
Study 11464232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11464232 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study 9290026 — intervention group
Group type: EXPERIMENTAL
Intervention: (THY 1-) fibroblasts non-containing lipids producing insulin-like growth factor 2 (ILGF 2), binding proteins 2 and 4, and epidermal growth factor receptors
Number of subjects: 35
Study 9290026 — intervention group
Group type: EXPERIMENTAL
Intervention: (THY 1+) fibroblasts containing lipids
Number of subjects: 35
Study 8218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural tooth structure (enamel)
Number of subjects: 10
Study 8218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth titanium
Number of subjects: 10
Study 8218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-sprayed titanium
Number of subjects: 10
Study 8218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite
Number of subjects: 10
Study 8218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival surfaces (cementum, plasma‐sprayed titanium, hydroxyapatite)
Number of subjects: 10
Study 2979110 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside (1 microgram/kg/min)
Number of subjects: 37
Study 2979110 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (0.7 microgram/kg/min)
Number of subjects: 37
Study 2979110 — intervention group
Group type: COMPARATOR
Intervention: Control (no vasodilator)
Number of subjects: 37
Study 29115008 — intervention group
Group type: EXPERIMENTAL
Intervention: Val30Met tafamidis
Number of subjects: 145
Study 29115008 — intervention group
Group type: EXPERIMENTAL
Intervention: non-Val30Met tafamidis
Number of subjects: 145
Study 29115008 — intervention group
Group type: COMPARATOR
Intervention: Val30Met placebo
Number of subjects: 145
Study 26268636 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 100 mg/day and amlodipine 5 mg/day (Irb/Am group)
Number of subjects: 60
Study 26268636 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 80 mg/day and amlodipine 5 mg/day (Val/Am group)
Number of subjects: 60